Hardik Parikh
Stock Analyst at J.P. Morgan
(0.36)
# 4,420
Out of 4,698 analysts
29
Total ratings
27.6%
Success rate
-11.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintained: Buy | $100 | $47.34 | +111.24% | 7 | Aug 17, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $30 | $15.74 | +90.60% | 2 | Aug 12, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $75 → $65 | $33.98 | +91.29% | 8 | Aug 11, 2026 | |
| PCRX Pacira BioSciences | Maintained: Sell | $23 | $26.60 | -13.53% | 12 | Aug 10, 2026 |
Structure Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $100
Current: $47.34
Upside: +111.24%
Kailera Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $30
Current: $15.74
Upside: +90.60%
Viking Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $75 → $65
Current: $33.98
Upside: +91.29%
Pacira BioSciences
Aug 10, 2026
Maintained: Sell
Price Target: $23
Current: $26.60
Upside: -13.53%